Workflow
Moelis & pany(MC)
icon
Search documents
Moelis (MC) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research· 2024-02-08 00:51
Moelis (MC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 45.45%. A quarter ago, it was expected that this investment bank would post earnings of $0.05 per share when it actually produced a loss of $0.15, delivering a surprise of -400%.Over the last four quarters, the company has surpas ...
Earnings Preview: Moelis (MC) Q4 Earnings Expected to Decline
Zacks Investment Research· 2024-01-31 16:06
Wall Street expects a year-over-year decline in earnings on lower revenues when Moelis (MC) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on February 7, 2024, might help the stock move higher if these key numbers are better than expectati ...
Moelis & Company to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on February 7, 2024
Businesswire· 2024-01-17 21:15
NEW YORK--(BUSINESS WIRE)--Moelis & Company (NYSE: MC), a leading global independent investment bank, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024. Ken Moelis, Chairman and Chief Executive Officer, and Joe Simon, Chief Financial Officer, will also host a related conference call at 5:00pm ET on the same day (February 7, 2024) to review the financial results. Following the review, there will be a question and answer session. In ...
Moelis & pany(MC) - 2023 Q3 - Quarterly Report
2023-11-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36418 Moelis & Company (Exact name of registrant as specified in its charter) Delaware 46-4500216 (State or other jurisdict ...
Moelis & pany(MC) - 2023 Q2 - Earnings Call Presentation
2023-08-10 12:31
July 2023 Investor Presentation Forward Looking Statements This presentation contains forward-looking statements, which reflect the Firm's current views with respect to, among other things, its operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "seeks," "target," "approximately," "predicts," "intends," "plans," "estimates," "anticipates" or the negative versio ...
Moelis & pany(MC) - 2023 Q2 - Earnings Call Transcript
2023-07-26 22:17
Moelis & Company (NYSE:MC) Q2 2023 Earnings Conference Call July 26, 2023 5:00 PM ET Company Participants Matt Tsukroff - Associate Joe Simon - Chief Financial Officer Ken Moelis - Chairman & Chief Executive Officer Conference Call Participants Ken Worthington - JPMorgan James Yaro - Goldman Sachs Brendan O'Brien - Wolfe Research Ben Rubin - UBS Financial Connell Schmitz - Morgan Stanley Devin Ryan - JMP Securities. Operator Good afternoon, and welcome to the Moelis & Company Earnings Conference Call for th ...
Moelis & pany(MC) - 2023 Q2 - Quarterly Report
2023-07-26 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Moelis & Company (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 399 Park Avenue, 4th Floor, New York NY 10022 (Address of principal executive offices) (Zip Code) Delaware 46-4500216 (I.R.S. Employer Identification No.) FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, ...
Moelis & pany(MC) - 2023 Q1 - Earnings Call Transcript
2023-04-27 02:50
Moelis & Company (NYSE:MC) Q1 2023 Earnings Conference Call April 26, 2023 5:00 PM ET Company Participants Matt Tsukroff - Investor Relations Ken Moelis - Chairman and Chief Executive Officer Joe Simon - Chief Financial Officer Conference Call Participants Devin Ryan - JMP Securities Ken Worthington - JPMorgan Matt Moon - KBW Brendan O’Brien - Wolfe Research Ben Rubin - UBS James Yaro - Goldman Sachs Ryan Kenny - Morgan Stanley Operator Good afternoon and welcome to the Moelis & Company Earnings Conference ...
Moelis & pany(MC) - 2023 Q1 - Quarterly Report
2023-04-26 16:00
[Part I. Financial Information](index=3&type=section&id=Part%20I.%20Financial%20Information) [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited condensed consolidated financial statements for Q1 2023, covering financial condition, operations, comprehensive income, cash flows, and equity, along with significant accounting policies [Condensed Consolidated Statements of Financial Condition](index=4&type=section&id=Condensed%20Consolidated%20Statements%20of%20Financial%20Condition) Total assets decreased to **$989.0 million** from **$1.22 billion**, and total liabilities decreased to **$556.9 million** from **$757.9 million**, primarily due to reduced cash, investments, and compensation payable Condensed Consolidated Statements of Financial Condition (in thousands) | Account | March 31, 2023 | December 31, 2022 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $134,622 | $206,794 | | Investments | $91,681 | $265,245 | | **Total assets** | **$989,028** | **$1,216,869** | | **Liabilities and Equity** | | | | Compensation payable | $29,230 | $243,176 | | **Total liabilities** | **$556,918** | **$757,931** | | **Total equity** | **$432,110** | **$458,938** | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Q1 2023 revenues fell **38%** to **$187.8 million**, resulting in an operating loss of **$1.4 million** and net income of **$3.7 million**, a significant decline from the prior year's performance Condensed Consolidated Statements of Operations (in thousands, except per share amounts) | Metric | Q1 2023 | Q1 2022 | | :--- | :--- | :--- | | Revenues | $187,820 | $302,088 | | Total expenses | $189,211 | $212,661 | | Operating income (loss) | $(1,391) | $89,427 | | Net income (loss) attributable to Moelis & Company | $3,666 | $65,715 | | Diluted EPS | $0.05 | $0.94 | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operating activities was **$152.1 million** due to compensation payments, while investing activities provided **$170.2 million**, leading to a **$72.2 million** net decrease in cash and cash equivalents for Q1 2023 Cash Flow Summary for the Three Months Ended March 31 (in thousands) | Activity | 2023 | 2022 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | $(152,143) | $(272,454) | | Net cash provided by (used in) investing activities | $170,217 | $27,360 | | Net cash provided by (used in) financing activities | $(90,557) | $(143,724) | | **Net increase (decrease) in cash** | **$(72,154)** | **$(389,959)** | [Notes to Condensed Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) These notes detail accounting policies, including revenue recognition for advisory services and the company's single business segment, also disclosing a **$0.60 per share** dividend and a new Los Angeles office lease post-quarter end - The company's activities as an investment banking advisory firm constitute a **single business segment**, offering services in M&A, recapitalizations, restructurings, and other corporate finance matters[24](index=24&type=chunk) - The vast majority of advisory services revenues are recognized **over time**, with variable transaction fees constrained until the transaction is substantially complete and revenue reversal is not probable[56](index=56&type=chunk)[57](index=57&type=chunk) - For Q1 2023, the company recognized **$59.6 million** in equity-based compensation expense, with **$242.5 million** in total unrecognized expense as of March 31, 2023, to be recognized over **2.1 years**[87](index=87&type=chunk)[91](index=91&type=chunk) - Subsequent to quarter end, the Board declared a **$0.60 per share** dividend, and the company entered a new Los Angeles office lease with an associated **$15.0 million** right-of-use asset and lease liability[123](index=123&type=chunk)[124](index=124&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=24&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the **38%** Q1 2023 revenue decrease to **$187.8 million** due to M&A market slowdown, analyzing operating results, liquidity, capital resources, and critical accounting policies, while noting strong client engagement [Results of Operations](index=26&type=section&id=Results%20of%20Operations) Q1 2023 revenues decreased **38%** to **$187.8 million**, leading to a **$1.4 million** operating loss, as compensation expenses rose to **79%** of revenue despite a **16%** decline, and non-compensation expenses increased **14%** Operating Results Summary (in thousands) | Item | Q1 2023 | Q1 2022 | Variance | | :--- | :--- | :--- | :--- | | Revenues | $187,820 | $302,088 | -38% | | Compensation and benefits | $148,239 | $176,637 | -16% | | Non-compensation expenses | $40,972 | $36,024 | 14% | | Operating income (loss) | $(1,391) | $89,427 | N/M | - The decrease in revenues was driven by a reduction in both the **number of completed transactions** and the **average fees per completed transaction** compared to the prior year period[141](index=141&type=chunk) - Compensation expenses as a percentage of revenue increased to **79%** in Q1 2023 from **58%** in Q1 2022, due to declining revenues and greater headcount[147](index=147&type=chunk) - Non-compensation expenses increased primarily due to higher **client travel** and **communication and technology expenses**, driven by greater headcount and more in-person client discussions[149](index=149&type=chunk) [Liquidity and Capital Resources](index=28&type=section&id=Liquidity%20and%20Capital%20Resources) The company maintains strong liquidity with **$135.4 million** in cash, **$65.0 million** and **$30.0 million** credit facilities, no borrowings, a **$0.60 per share** dividend declared, and **$62.5 million** remaining in its share repurchase program - As of March 31, 2023, the company had **$85.4 million** in cash and cash equivalents and **$49.2 million** in cash[156](index=156&type=chunk) - The company maintains two credit facilities: a **$65.0 million** revolving credit facility and a **$30.0 million** facility for its U.S. Broker Dealer, with **no borrowings** under either as of March 31, 2023[159](index=159&type=chunk)[162](index=162&type=chunk) - The Board of Directors declared a regular quarterly dividend of **$0.60 per share**, payable on June 23, 2023[163](index=163&type=chunk) - The share repurchase program, authorized in July 2021 for up to **$100 million**, had a remaining balance of **$62.5 million** as of March 31, 2023[164](index=164&type=chunk)[97](index=97&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=33&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company faces no significant market risk due to its non-capital-intensive model, though it has unhedged foreign currency exposure and manages credit risk through an allowance for credit losses - The company's business is **not capital-intensive**, and it does not invest in derivatives or generally borrow through debt, resulting in **no significant market risk**[176](index=176&type=chunk) - The company is exposed to **foreign exchange rate risk**, particularly between the U.S. dollar and the pound sterling, euro, and other currencies, with a net impact of a **$0.3 million gain** for Q1 2023[179](index=179&type=chunk) - Credit risk is managed by regularly reviewing accounts receivable and maintaining an **allowance for credit losses** based on historical experience, credit quality, and economic conditions[178](index=178&type=chunk) [Controls and Procedures](index=33&type=section&id=Item%204.%20Controls%20and%20Procedures) Management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of March 31, 2023, with no material changes to internal control over financial reporting during the quarter - The Chief Executive Officer and Chief Financial Officer concluded that the company's **disclosure controls and procedures were effective** as of the end of the period covered by the report[195](index=195&type=chunk) - **No material change** in internal control over financial reporting occurred during the quarter[196](index=196&type=chunk) [Part II. Other Information](index=34&type=section&id=Part%20II.%20Other%20Information) [Legal Proceedings](index=34&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in ordinary course legal and regulatory proceedings, including an SEC inquiry into recordkeeping and a class action lawsuit challenging its Stockholders Agreement, with potential losses currently inestimable - The company is cooperating with an **SEC request for information** related to an industry-wide investigation of broker-dealer practices for recordkeeping of business communications on messaging applications[198](index=198&type=chunk) - A **class action lawsuit** was filed by a stockholder in the Delaware Court of Chancery seeking a declaratory judgment that certain provisions of the Stockholders Agreement are invalid and unenforceable[198](index=198&type=chunk) [Risk Factors](index=34&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2022 - **No material changes** to the Risk Factors described in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, have occurred[200](index=200&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=34&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered equity sales, repurchasing **1,057,278 shares** at an average of **$42.11** in Q1 2023, with **$62.5 million** remaining in the share repurchase program Issuer Purchases of Equity Securities in Q1 2023 | Period | Total Number of Shares Purchased | Average Price Paid per Share | Approximate Dollar Value of Shares that May Yet be Purchased Under the Plan | | :--- | :--- | :--- | :--- | | Jan 1 - Jan 31 | — | $— | $62.5 million | | Feb 1 - Feb 28 | 1,026,616 | $42.09 | $62.5 million | | Mar 1 - Mar 31 | 30,662 | $42.85 | $62.5 million | | **Total** | **1,057,278** | **$42.11** | **$62.5 million** | - In July 2021, the Board authorized the repurchase of up to **$100 million** of Class A common stock and/or Class A partnership units with no expiration date[202](index=202&type=chunk) [Defaults Upon Senior Securities](index=34&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reported no defaults upon senior securities during the period - None [Mine Safety Disclosures](index=35&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - Not applicable [Other Information](index=35&type=section&id=Item%205.%20Other%20Information) The company reports no information for this item - None [Exhibits](index=36&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including corporate governance documents, vesting agreements, and CEO/CFO certifications required by Sarbanes-Oxley Act - The report includes **CEO and CFO certifications** pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002[207](index=207&type=chunk) - **Inline XBRL documents** are included as exhibits for interactive data filing[207](index=207&type=chunk)
Moelis & pany(MC) - 2022 Q4 - Annual Report
2023-02-22 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36418 (Exact name of registrant as specified in its charter) (State or other jurisdiction of (I.R.S. Employer incorporation or organ ...